Revolutionary Microneedle Patches Transform Diabetic Wound Healing
The Challenge of Diabetic Wounds
Diabetic wounds are a major health issue, often leading to severe complications such as amputations. These chronic wounds are characterized by persistent inflammation, affecting over 6% of people worldwide. In Singapore alone, about four lower limb amputations occur daily due to non-healing diabetic wounds.
Economic Impact of Diabetic Complications
The financial burden of treating diabetic wounds is significant. A study in Singapore estimated that the healthcare cost per patient related to amputations was S$23,000 (approximately $17,400 USD) in 2017. These high costs underscore the urgent need for effective treatments to accelerate wound healing and reduce complications.
Innovative Microneedle Technology by NUS
Researchers at the National University of Singapore have developed two groundbreaking microneedle technologies aimed at speeding up diabetic wound healing. These microneedles help preserve growth factors essential for healing and remove harmful inflammatory compounds, offering a promising new approach to treating chronic wounds.
SUC-MN: Enhancing Growth Factor Production
The first microneedle innovation, known as Sucralfate Microneedles (SUC-MN), delivers interleukin-4 (IL-4) to wounds. IL-4 stimulates the production of growth factors in diabetic tissues, promoting tissue regeneration. Additionally, sucralfate protects these growth factors from degradation, resulting in wound healing that is twice as fast as traditional treatments.
HPMN: Tackling Inflammation at the Source
The second approach utilizes Heparin-coated Porous Microneedles (HPMN) to reduce inflammation. These microneedles extract pro-inflammatory compounds and immune cells from the wound, cutting tissue inflammation by 50% and reducing wound size by 90% within two weeks. This method offers a unique advantage by addressing deep tissue inflammation effectively.
Future Prospects and Clinical Translation
Looking ahead, the NUS team plans to refine their microneedle technologies by using advanced methods like 3D printing to control pore sizes and incorporating antibacterial properties. They are also designing flexible patches to fit various tissue shapes, aiming to bring these innovations to market and provide relief for patients with diabetic wounds and other skin conditions.
Conclusion
The development of SUC-MN and HPMN by the National University of Singapore marks a significant advancement in wound healing technology. These innovative microneedles offer effective solutions for accelerating diabetic wound healing and reducing inflammation, promising improved outcomes for patients and a reduction in healthcare costs associated with chronic wounds.
Read the full article here:
futurity.org